SCHEMBL31377131

SCHEMBL31377131

O=C(O)C1CN(CC2CCOCC2)C1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GBA1 P04062 2/20 0.49
▸ TACR2 P21452 1/20 0.39
▸ TSHR P16473 1/20 0.39
▸ OPRM1 P35372 2/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ JAK1 P23458 1/20 0.36
▸ TYK2 P29597 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ HTR4 Q13639 2/20 0.36
▸ CYP3A4 P08684 1/20 0.36
▸ S1PR1 P21453 3/20 0.36
▸ S1PR5 Q9H228 3/20 0.36
▸ CNR1 P21554 1/20 0.35
▸ CNR2 P34972 1/20 0.35
▸ SCN1A P35498 1/20 0.35
▸ SCN4A P35499 1/20 0.35
▸ SCN7A Q01118 1/20 0.35
▸ KCNH2 Q12809 1/20 0.35
▸ SCN5A Q14524 1/20 0.35
▸ SCN9A Q15858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4678458 0.86 PLG (0.45) JAK2JAK1TYK2JAK3S1PR1
SCHEMBL17873962 0.82 SMN1; SMN2 (0.43) GBA1JAK2JAK1TYK2JAK3
SCHEMBL13905846 0.82 SMN1; SMN2 (0.47) GBA1JAK2JAK1TYK2JAK3
SCHEMBL13905729 0.81 SMN1; SMN2 (0.50) GBA1KDM2BCHRM2CHRM4
SCHEMBL28688228 0.76 TSHR (0.49) TSHRPLGPLATLMNA
SCHEMBL16209856 0.76 TSHR (0.49) TSHRPLGPLATLMNA
SCHEMBL4731247 0.76 SMN1; SMN2 (0.46) GBA1TACR2OPRM1KDM2B
SCHEMBL3602019 0.73 TACR2 (0.49) GBA1TACR2TSHR
SCHEMBL23963905 0.72 GBA1 (0.50) GBA1OPRM1HTR4CYP3A4SCN1A
SCHEMBL13905847 0.72 TSHR (0.43) TSHRKDM2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025064683-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-27 — — WO disclosed
US-20250091989-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS Interdict Bio, Inc. (US) 2025-03-20 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250091989-A1 SMALL MOLECULE PROTEIN SYNTHESIS MODULATORS MYC, KRAS, NRAS GBA1 2357/4885TACR2 4292/4885TSHR 3881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback